Selection criteria for postmastectomy radiotherapy in T1-T2 tumors with 1 to 3 positive lymph nodes Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Carcinoma, Ductal, Breast
  • Lymph Nodes
  • Mastectomy
  • Neoplasm Recurrence, Local
  • Patient Selection
  • Radiotherapy, Adjuvant

abstract

  • By using clinicopathologic features, clinicians delivered PMRT to a select group of patients with T1-T2 tumors and 1 to 3 positive ALN, resulting in similarly low rates of 5-year LRR. Among patients not receiving PMRT, age ≤50 years and LVI were associated with increased LRR rates and warrant PMRT consideration.

publication date

  • October 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1245/s10434-013-3117-0

PubMed ID

  • 23975289

Additional Document Info

start page

  • 3169

end page

  • 74

volume

  • 20

number

  • 10